Establishment and influencing factors of type II collagen induced murine arthritis model

Chinese Pharmacological Bulletin

Volumn 22, Issue 12, 2006, Pages 1532-1535

  Zhou, Ru ^a   Yang, Yi Fu ^a   Zuo, Jian Ping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Collagen; Murine arthritis; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2;

ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; JOINT DESTRUCTION; MEDICAL RESEARCH; NONHUMAN; POLYARTHRITIS; RHEUMATOID ARTHRITIS; RISK FACTOR;

EID: 33847055507     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Trentham D E, Townes A S, Kang A H. Autoimmunity to type II collagen an experimental model of arthritis[J]. J Exp Med, 1977, 146: 857-68.
2. Courtenay J S, Dallman M J, Dayan A D, et al. Immunisation against heterologous type II collagen induces arthritis in mice[J]. Nature, 1980,283: 666-8.
3. Joe B, Wilder R L. Animal models of rheumatoid arthritis[J]. Mol Med Today, 1999,5: 367-9.
4. Myers L K, Rosloniec E F, Cremer M A, Kang A H. Collagen-induced arthritis, an animal model of autoimmunity[J]. Life Sci, 1997,61:1861-78.
5. Fournier C. Where do T cells stand in rheumatoid arthritis[J]? Joint Bone Spine, 2005,72: 527-32.
6. Brand D D, Kang A H, Rosloniec E F. Immunopathogenesis of collagen arthritis[J]. Springer Semin Immunopathol, 2003,25: 3-18.
7. Bao L Y, Lu R, Li G L, et al. Effect of tetrapeptides compound CMST1 on treatment of adjuvant arthritis in rats [J]. Chin Pharmacol Bull, 2005,21(9): 1148-9.
8. 2 and rheumatoid arthritis with drug development[J]. Chin Pharmacol Bull, 2005,21(3): 262-6.
9. Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis[J]. Rheumatol Oxford, 2004,43(Suppl 3): 2-9.
10. Nishimoto N, Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases [J]. Curr Opin Pharmacol, 2004,4: 386-91.
11. Rosloniec E F, Latham K, Guedez Y B. Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity[J]. Arthritis Res, 2002,4:333-6.
12. Finnegan A, Grusby M J, Kaplan C D, et al. IL4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms [J]. J Immunol, 2002,169: 3345-52.
13. Myers L K, Tang B, Stuart J M, Kang A H. The role of IL-4 in regulation of murine collagen-induced arthritis[ J]. Clin Immunol, 2002,102: 185-91.
14. St Clair E W. Interleukin-10: therapeutic prospects in rheumatoid arthritis[J]. Curr Dir Autoimmun, 2000,2: 126-49.
15. Wahl S M, Chen W. Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases[J]. Arthritis Res Ther, 2005,7: 62-8.
16. Muller-Ladner U, Gay R E, Gay S. Role of nuclear factor kappaB in synovial inflammation [J]. Curr Rheumatol Rep, 2002,4: 201-7.
17. Ochi T, Ohkubo Y, Mutoh S. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice [J]. Biochem Pharmacol, 2003,66: 1055-60.
18. Hu C M, Li J, Jin Y, Peng L. The relationship between therapeutic effects and concentration in tissue or serum of Mel G[J]. Chin Pharmacol Bull, 2004, 20(8): 890-3.
19. Shi W, Wang Y M, Li S L, et al. Cohort study of quality of life (QOL) after 6 months of therapy by diclofenac, nabumetone, meloxicam or celecoxib in patients with rheumatoid arthritis [J]. Chin Pharmacol Bull, 2004, 20(6):636-40.
20. van der Pouw Kraan T C, van Gaalen F A, et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues[J]. Arthritis Rheum,2003,48: 2132-45.
21. Frucht D M, Aringer M, Galon J, et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation [J]. J Immunol, 2000,164: 4659-64.
22. Zhou R, Tang W, Ren Y X, et al. (5R)-5-hydroxytriptolide (LL-DT-8) prevented collagen-induced arthritis in DBA/1 mice via suppressing IFN-gamma production and its related signaling [J]. J Pharmacol Exp Ther, 2006,318(1):35-44.
23. Szekanecz Z, Kim J, Koch A E. Chemokines and chemokine receptors in rheumatoid arthritis [J]. Semin Immunol, 2003,15(1): 15-21.
24. Neumann E, Gay S, Muller-Ladner U. The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal models [J]. Arthritis Rheum, 2005,52: 2960-7.